FMC/Alemtuzumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide, fludarabine, mitoxantrone and alemtuzumab that may be used in the treatment of T-cell prolymphocytic leukemia.

**Synonyms:** - Alemtuzumab-FMC - Alemtuzumab/Cyclophosphamide/Fludarabine/Mitoxantrone - FMC Plus Alemtuzumab - FMC-Alemtuzumab - Fludarabine/Mitoxantrone/Cyclophosphamide/Alemtuzumab